Our mission is to develop a collaborative global network of Alpha-1 patient leaders, physicians, and researchers, to increase awareness, detection, and access to care for Alphas around the world.
29 September 2020, 15:00 – 16:30 hrs Online event co-organised with the support of MEP Sirpa Pietikainen (EPP, Finland) Platform of Plasma Protein Users is …
Read More
Z Factor, the Cambridge-based drug development company created by European life sciences-oriented venture capital company Medicxi in partnership with the University of Cambridge in 2015, …
Read More
UPDATED 12 October 2020: RPP Group, a Brussels-based public policy and advocacy consultant, has produced a monitoring service that will be disseminated regularly, providing timely …
Read More
Study on liver involvement in mild alpha-1-antitrypsin deficiency published in “Gastroenterology” The Alpha1-Liver Team from Aachen, Germany, which coordinates the European study group for alpha1-antitrypsin …
Read More
On 3 May 2020, The Wall Street Journal published an article entitled “Researchers Explore Using Common Blood-Plasma Treatment to Fight Coronavirus.” The article discussed the …
Read More
25 April 2020 marked the third annual European Alpha-1 Awareness Day, a date in which those afflicted with the genetic condition Alpha-1 Antitrypsin Deficiency (AATD) …
Read More
25 April 2020 will mark the third annual European Alpha-1 Awareness Day, which is dedicated to raising awareness for those with Alpha-1 Antitrypsin Deficiency. Alpha-1 …
Read More
Barcelona, March 25, 2020 – Grifols today announces that it has entered into a formal collaboration with the United States Biomedical Advanced Research Development Authority (BARDA), …
Read More
CSL continues to provide medicines to patients around the world. Safeguarding our people, patients and donors remains our top priority. As the COVID-19 pandemic evolves, …
Read More
Nuccia Gatta, President of Alfa-1-At Onlus Italia, has authored the following communication on the current situation in Italy for Alpha-1 patients following the COVID-19 outbreak …
Read More